Norlase
Ballerup
About Norlase
Norlase is an emerging global ophthalmic medical device company developing next-generation laser solutions for the treatment of retina and glaucoma disease. Norlase offers innovative ophthalmic laser solutions, including ECHO and LEAF. ECHO, recognized as the world's first truly portable pattern laser, is battery-powered and equipped with a wireless user interface featuring voice control capabilities. Its design eliminates the need for fiber tethers, enhancing both portability and treatment flexibility. Meanwhile, LEAF is an ultra-compact green laser photocoagulator that attaches directly to existing slit lamps, streamlining laser treatments by removing the need for external fibers or additional equipment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $45.2M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Feb 2025)
- Website: norlase.com
- Phone: +45 9397 7472
Industries & Categories
Laser, Machinery Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/norlase-62694 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.